UK markets closed

4D pharma plc (DDDD.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
103.00+3.10 (+3.10%)
At close: 4:35PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 5185.71M
Enterprise value 3120.54M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)269.14
Price/book (mrq)347.97
Enterprise value/revenue 3174.69
Enterprise value/EBITDA 7-3.53

Trading information

Stock price history

Beta (5Y monthly) 2.81
52-week change 3135.61%
S&P500 52-week change 335.41%
52-week high 3183.00
52-week low 335.01
50-day moving average 399.25
200-day moving average 3113.86

Share statistics

Avg vol (3-month) 32.22M
Avg vol (10-day) 31.67M
Shares outstanding 5180.3M
Implied shares outstanding 6N/A
Float 88.43M
% held by insiders 136.32%
% held by institutions 126.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,175.22%

Management effectiveness

Return on assets (ttm)-49.64%
Return on equity (ttm)-86.93%

Income statement

Revenue (ttm)690k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)16.90%
Gross profit (ttm)690k
EBITDA -34.14M
Net income avi to common (ttm)-30.5M
Diluted EPS (ttm)-19.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.99M
Total cash per share (mrq)0.09
Total debt (mrq)1.19M
Total debt/equity (mrq)3.06
Current ratio (mrq)2.45
Book value per share (mrq)0.30

Cash flow statement

Operating cash flow (ttm)-27.27M
Levered free cash flow (ttm)-17.74M